Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces

Autor: Finlay A. McAlister, Ting Wang, Xuesong Wang, Anna Chu, Shaun G. Goodman, Sean van Diepen, Cynthia A. Jackevicius, Padma Kaul, Jacob Udell, Dennis T. Ko, Jeffrey C. Kwong, Peter C. Austin, Douglas S. Lee, Husam Abdel‐Qadir, Charles de Mestral, Shaun Goodwin, Andrew Ha, Moira Kapral, Jeff Kwong, Paula Rochon, Idan Roifman, Heather Ross, Michael Schull, Louise Sun, Bo Wang, Harindra Wijeysundera, Amy Yu, Kevin Bainey, Jeff Bakal, Justin Ezekowitz, Russ Greiner, Sunil Kalmady, Robert Welsh, Cindy Westerhout, Peter Liu, Roopinder Sandhu

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 21 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Background Small observational studies have suggested that statin users have a lower risk of dying with COVID‐19. We tested this hypothesis in a large, population‐based cohort of adults in 2 of Canada’s most populous provinces: Ontario and Albe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccaff69e1f38629937dc72138f5c6ce2
https://www.ahajournals.org/doi/10.1161/JAHA.121.022330